CG Oncology
CG Oncology is seeking a seasoned Vice President of Financial Planning & Analysis to drive financial insight, forecasting, and strategic decision support as the company advances through commercialization and growth. The role involves leading enterprise-wide planning, budgeting, and forecasting, collaborating cross-functionally, and serving as a trusted advisor to senior leadership. The position offers remote work and involves engagement with both clinical and commercial teams to support product launch and revenue forecasting.
CG Oncology is a late-stage biopharmaceutical company focused on developing bladder‑sparing immunotherapies for bladder cancer. The company specializes in oncolytic immunotherapy and is advancing cretostimogene grenadenorepvec as a lead therapeutic candidate. CG Oncology’s programs aim to provide non-surgical, targeted treatment options that preserve the bladder and improve outcomes for patients with bladder cancer. They emphasize clinical development and commercialization readiness to bring these innovative therapies to market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CG Oncology.
176% above the average for this role
Senior Vice President– Financial Planning, Analysis & Budgeting
CVC Marathon
Vice President, Financial Planning & Analysis (FP&A)
Stratus
Senior Director, FP&A
Vir Biotechnology
Director, FP&A
Cadent
Financial Planning and Analysis (FP&A) Manager
CreatorIQ
Vice President, Strategic Financial Planning & Analysis
BlackRock